Download PDF
Exp Clin Endocrinol Diabetes 2019; 127(04): 195-202
DOI: 10.1055/s-0043-122223
Article
© Georg Thieme Verlag KG Stuttgart · New York

Expression and Significance of MMPs in Synovial Fluid, Serum and PBMC Culture Supernatant Stimulated by LPS in Osteoarthritis Patients With or Without Diabetes

Simin Luo   *
1   The First Affiliated Hospital, Jinan University, Guangzhou, China
2   Institute of Orthopaedic Disease Research, Jinan University, Guangzhou, China
,
Qiping Shi   *
1   The First Affiliated Hospital, Jinan University, Guangzhou, China
,
Junyuan Chen   *
1   The First Affiliated Hospital, Jinan University, Guangzhou, China
2   Institute of Orthopaedic Disease Research, Jinan University, Guangzhou, China
,
Huajun Wang
1   The First Affiliated Hospital, Jinan University, Guangzhou, China
2   Institute of Orthopaedic Disease Research, Jinan University, Guangzhou, China
,
Wenrui Wu
1   The First Affiliated Hospital, Jinan University, Guangzhou, China
2   Institute of Orthopaedic Disease Research, Jinan University, Guangzhou, China
,
Zhengang Zha
1   The First Affiliated Hospital, Jinan University, Guangzhou, China
2   Institute of Orthopaedic Disease Research, Jinan University, Guangzhou, China
› Author Affiliations
Further Information

Publication History

received 08 June 2017
revised 08 October 2017

accepted 30 October 2017

Publication Date:
21 December 2017 (online)

Also available at
   Permissions and Reprints

Abstract

Objective Patients with Type 2 Diabetes mellitus (T2DM) are prone to osteoarthritis (OA). Matrix metalloproteinases (MMPs), an essential modulator in cartilage matrix homeostasis, increase in T2DM and OA. We aimed to ascertain the expression difference of MMPs and function in mononuclear cells after stimulating by lipopolysaccharide (LPS) in OA patients with or without diabetes.

Methods 30 knee OA patients without T2DM (OA group), 20 knee OA patients with T2DM (DM-OA group) and 5 healthy volunteers recruited as control were enrolled from January 2016 to January 2017. The expression levels of MMPs in both serum and synovial fluid were initially detected in three groups by enzyme-linked immunosorbent assay (ELISA). After stimulation of peripheral blood mononuclear cell (PBMC) with LPS, the release of MMPs were determined and evaluated.

Results The expression of MMP-1, -7, -8, -9, -10 and -12 in synovial fluid in DM-OA group were significantly higher than in OA group and healthy control. The expression of MMP-1 and -7 in serum were highest in DM-OA group. LPS significantly promotes the production of MMP-1, -8, -9 and -10 in PBMC of each group after 4 h stimulation. It is worth to note that the LPS-stimulated MMP-8 and -9 elevations were more prominent in DM-OA group compared with their counterparts.

Conclusion High levels of MMP-1, -7, -8, -9, -10, and -12 in the synovial fluid might be one of important reasons that diabetes patients are more frequently suffered from OA. Inflammation-induced malfunction of mononuclear cells would stimulate MMP-8 and -9 secretion to various extents.

Key words

Osteoarthritis - Type 2 Diabetes mellitus - Matrix metalloproteinase - Peripheral Blood Mononuclear Cell

* Contribute equally to this paper.


 

  • References

  • 1 Martel-Pelletier J, Boileau C, Pelletier JP. et al. Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol 2008; 22: 351-384
    CrossrefPubMedGoogle Scholar
  • 2 White DK, Neogi T, Nguyen US. et al. Trajectories of functional decline in knee osteoarthritis: The Osteoarthritis Initiative. Rheumatology (Oxford) 2016; 55: 801-808
    CrossrefPubMedGoogle Scholar
  • 3 Ailixiding M, Aibibula Z, Iwata M. et al. Pivotal role of Sirt6 in the crosstalk among ageing, metabolic syndrome and osteoarthritis. Biochem Biophys Res Commun 2015; 466: 319-326
    CrossrefPubMedGoogle Scholar
  • 4 Askari A, Ehrampoush E, Homayounfar R. et al. Serum insulin in pathogenesis and treatment of osteoarthritis. Med Hypotheses 2017; 99: 45-46
    CrossrefPubMedGoogle Scholar
  • 5 Bourboulia D, Stetler-Stevenson WG. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 2010; 20: 161-168
    CrossrefPubMedGoogle Scholar
  • 6 Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol 2007; 213: 626-634
    CrossrefPubMedGoogle Scholar
  • 7 Jackson MT, Moradi B, Smith MM. et al. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes. Arthritis Rheumatol 2014; 66: 1525-1536
    PubMedGoogle Scholar
  • 8 Tio L, Martel-Pelletier J, Pelletier JP. et al. Characterization of opticin digestion by proteases involved in osteoarthritis development. Joint Bone Spine 2014; 81: 137-141
    CrossrefPubMedGoogle Scholar
  • 9 Heard BJ, Martin L, Rattner JB. et al. Matrix metalloproteinase protein expression profiles cannot distinguish between normal and early osteoarthritic synovial fluid. BMC Musculoskelet Disord 2012; 13: 126
    CrossrefPubMedGoogle Scholar
  • 10 Xue M, McKelvey K, Shen K. et al. Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation. Rheumatology (Oxford) 2014; 53: 2270-2279
    CrossrefPubMedGoogle Scholar
  • 11 Buhrmann C, Mobasheri A, Matis U. et al. Curcumin mediated suppression of nuclear factor-κB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment. Arthritis Res Ther 2010; 12: R127
    CrossrefPubMedGoogle Scholar
  • 12 Henrotin Y, Clutterbuck AL, Allaway D. et al. Biological actions of curcumin on articular chondrocytes. Osteoarthritis and cartilage 2010; 18: 141-149
    CrossrefPubMedGoogle Scholar
  • 13 Courties A, Sellam J. Osteoarthritis and type 2 diabetes mellitus: What are the links?. Diabetes Res Clin Pract 2016; 122: 198-206
    CrossrefPubMedGoogle Scholar
  • 14 Ribeiro M, Lopez de Figueroa P, Nogueira-Recalde U. et al. Diabetes-accelerated experimental osteoarthritis is prevented by autophagy activation. Osteoarthritis and cartilage 2016; 24: 2116-2125
    CrossrefPubMedGoogle Scholar
  • 15 Berenbaum F. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Ann Rheum Dis 2011; 70: 1354-1356
    CrossrefPubMedGoogle Scholar
  • 16 Yoshimura N, Muraki S, Oka H. et al. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. Osteoarthritis Cartilage 2012; 20: 1217-1226
    CrossrefPubMedGoogle Scholar
  • 17 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes care 2014; 37 (Suppl. 01) S81-S90
    CrossrefPubMedGoogle Scholar
  • 18 Archer CW, Francis-West P. The chondrocyte. Int J Biochem Cell Biol 2003; 35: 401-404
    CrossrefPubMedGoogle Scholar
  • 19 Itka O, Kukacka J, Krizkova S. et al Matrix metalloproteinases. Curr Med Chem 2010; 17: 3751-3768
    CrossrefPubMedGoogle Scholar
  • 20 Galasso O, Familiari F, De Gori M. et al. Recent findings on the role of gelatinases (matrix metalloproteinase-2 and -9) in osteoarthritis. Adv Orthop 2012; 2012: 834208
    PubMedGoogle Scholar
  • 21 Catterall JB, Stabler TV, Flannery CR. et al. Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254). Arthritis Res Ther 2010; 12: R229
    CrossrefPubMedGoogle Scholar
  • 22 Tchetverikov I, Lohmander LS, Verzijl N. et al. MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis. Ann Rheum Dis 2005; 64: 694-698
    CrossrefPubMedGoogle Scholar
  • 23 Haller JM, Swearingen CA, Partridge D. et al. Intraarticular matrix metalloproteinases and aggrecan degradation are elevated after articular fracture. Clin Orthop Relat Res 2015; 473: 3280-3288
    CrossrefPubMedGoogle Scholar
  • 24 Hart DJ, Doyle DV, Spector TD. Association between metabolic factors and knee osteoarthritis in women: The Chingford study. J Rheumatol 1995; 22: 1118-1123
    PubMedGoogle Scholar
  • 25 Courties A, Sellam J, Berenbaum F. Metabolic syndrome-associated osteoarthritis. Curr Opin Rheumatol 2017; 29: 214-222
    CrossrefPubMedGoogle Scholar
  • 26 Chadha R. Revealed aspect of metabolic osteoarthritis. J Orthop 2016; 13: 347-351
    PubMedGoogle Scholar
  • 27 Andereya S, Streich N, Schmidt-Rohlfing B. et al. Comparison of modern marker proteins in serum and synovial fluid in patients with advanced osteoarthrosis and rheumatoid arthritis. Rheumatol Int 2006; 26: 432-438
    CrossrefPubMedGoogle Scholar
  • 28 Rosa SC, Rufino AT, Judas FM. et al. Role of glucose as a modulator of anabolic and catabolic gene expression in normal and osteoarthritic human chondrocytes. J Cell Biochem 2011; 112: 2813-2824
    CrossrefPubMedGoogle Scholar
  • 29 Kevorkian L, Young DA, Darrah C. et al. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 2004; 50: 131-141
    CrossrefPubMedGoogle Scholar
  • 30 Takaishi H, Kimura T, Dalal S. et al. Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr Pharm Biotechnol 2008; 9: 47-54
    CrossrefPubMedGoogle Scholar
  • 31 Bauvois B. New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim Biophys Acta 2012; 1825: 29-36
    PubMedGoogle Scholar
  • 32 Fernandes JC, Martel-Pelletier J, Pelletier JP. The role of cytokines in osteoarthritis pathophysiology. Biorheology 2002; 39: 237-246
    PubMedGoogle Scholar
  • 33 Tao Y, Qiu X, Xu C. et al. Expression and correlation of matrix metalloproteinase-7 and interleukin-15 in human osteoarthritis. Int J Clin Exp Pathol 2015; 8: 9112-9118
    PubMedGoogle Scholar
  • 34 Zeng GQ, Chen AB, Li W. et al. High MMP-1, MMP-2, and MMP-9 protein levels in osteoarthritis. Genet Mol Res 2015; 14: 14811-14822
    CrossrefPubMedGoogle Scholar
  • 35 Marques-Vidal P, Schmid R, Bochud M. et al. Adipocytokines, hepatic and inflammatory biomarkers and incidence of type 2 diabetes. The CoLaus Study. PLoS One 2012; 7: e51768
    CrossrefPubMedGoogle Scholar
  • 36 Calle MC, Fernandez ML. Inflammation and type 2 diabetes. Diabetes Metab 2012; 38: 183-191
    CrossrefPubMedGoogle Scholar
  • 37 Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001; 44: 1237-1247
    CrossrefPubMedGoogle Scholar
  • 38 Death AK, Fisher EJ, McGrath KC. et al. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. Atherosclerosis 2003; 168: 263-269
    CrossrefPubMedGoogle Scholar
  • 39 Richardson S, Neama G, Phillips T. et al. Molecular characterization and partial cDNA cloning of facilitative glucose transporters expressed in human articular chondrocytes; Stimulation of 2-deoxyglucose uptake by IGF-I and elevated MMP-2 secretion by glucose deprivation. Osteoarthritis and cartilage 2003; 11: 92-101
    CrossrefPubMedGoogle Scholar
  • 40 McNulty AL, Stabler TV, Vail TP. et al. Dehydroascorbate transport in human chondrocytes is regulated by hypoxia and is a physiologically relevant source of ascorbic acid in the joint. Arthritis Rheum 2005; 52: 2676-2685
    CrossrefPubMedGoogle Scholar
  • 41 Nakamura H, Shibakawa A, Tanaka M. et al. Effects of glucosamine hydrochloride on the production of prostaglandin E2, nitric oxide and metalloproteases by chondrocytes and synoviocytes in osteoarthritis. Clin Exp Rheumatol 2004; 22: 293-299
    PubMedGoogle Scholar
  • 42 Martel-Pelletier J, Welsch DJ, Pelletier JP. Metalloproteases and inhibitors in arthritic diseases. Best Pract Res Clin Rheumatol 2001; 15: 805-829
    CrossrefPubMedGoogle Scholar